No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
434 |
4. Check minimum number of eventsNone |
434 |
5. Include endpointsNone |
434 |
6. Filter based on genotype QC (FinnGen only) |
418 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of renal pelvis, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 418 | 107 | 311 |
| Unadjusted period prevalence (%) | 0.12 | 0.04 | 0.14 |
| Median age at first event (years) | 71.07 | 70.35 | 71.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 434
- Matched controls
- 4340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
307.7
398
*
UKC02
NOMESCO Finland
Cystoscopy
26.8
264.9
332
470
R31
ICD-10 Finland
Unspecified haematuria
17.1
206.2
251
323
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
194.9
172
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
54.3
161.3
94
22
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
157.1
141
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
37.2
145.7
94
32
130
Kela drug reimbursment
Malignant tumour
+∞
144.0
130
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
63.2
138.9
78
15
WX302
NOMESCO Finland
Thoracal epidural anesthesy
39.5
136.3
86
27
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
878.8
135.4
126
*
H02AB02
ATC
dexamethasone; systemic
47.2
135.0
81
21
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
128.7
117
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
124.1
113
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
259.7
117.0
115
6
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
116.0
106
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
70.8
111.2
61
10
JN4AD
NOMESCO Finland
Body CT examination
13.3
107.5
116
116
B01AB10
ATC
tinzaparin; parenteral
11.1
93.3
114
135
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
1082.1
92.4
87
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
53.6
90.0
52
11
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
14.9
88.3
85
70
Z51.5
ICD-10 Finland
Palliative care
13.3
86.5
90
84
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
335.9
83.7
82
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
251.9
82.5
82
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
80.8
75
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.9
77.8
131
226
JN4CD
NOMESCO Finland
Very extensive body CT
24.5
73.9
54
25
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
177.8
72.5
74
5
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
70.8
66
*
A04AA01
ATC
ondansetron; systemic, rectal
21.1
69.4
54
29
JN4BD
NOMESCO Finland
Extensive body CT
10.1
67.0
84
101
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
63.1
59
*
TPH07
NOMESCO Finland
Cathetrisation of artery
6.1
56.0
119
254
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
54.3
51
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.7
50.9
115
258
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
120.4
50.0
53
5
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
50.0
47
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.3
49.6
64
79
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
19.1
49.5
40
23
A04AA02
ATC
granisetron; systemic, transdermal
+∞
48.9
46
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
510.0
47.2
46
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
497.5
46.2
45
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.6
45.6
82
147
U06
ICPC
Haematuria
11.8
42.4
45
42
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
42.4
40
*
KH1AD
NOMESCO Finland
CT of urinary organs
9.4
42.1
53
63
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
10.1
42.1
50
55
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
17.5
40.5
34
21
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
38.1
36
*
WX402
NOMESCO Finland
General anaesthesia
4.4
36.6
113
322
116
Kela drug reimbursment
Prostate cancer
+∞
35.9
34
*
B01AB05
ATC
enoxaparin; parenteral
3.5
35.1
190
791
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
33.9
153
566
ZX136
NOMESCO Finland
Intravesicalis
352.5
33.4
33
*
N02AA05
ATC
oxycodone; systemic
3.9
33.1
122
393
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
32.7
31
*
B02AA02
ATC
tranexamic acid; systemic
5.3
32.7
74
163
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.8
31.7
38
42
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
30.6
29
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.4
30.3
150
582
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
30.0
83
215
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
29.5
28
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
29.5
28
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
29.5
28
*
8130/2-C65.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of renal pelvis
+∞
28.4
27
*
WW500
NOMESCO Finland
Blood transfusion
10.1
28.3
33
35
WZC30
NOMESCO Finland
Teaching
4.1
27.5
89
259
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
27.4
26
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.8
26.6
96
301
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.1
25.6
40
61
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
51.6
24.6
29
6
L03AA02
ATC
filgrastim; parenteral
253.4
23.9
24
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.1
23.4
72
201
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
38.7
23.3
29
8
J01MA02
ATC
ciprofloxacin; systemic
2.7
23.0
224
1226
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
88.3
22.9
25
*
KC1GB
NOMESCO Finland
Cystography with X-ray
88.3
22.9
25
*
L02AE02
ATC
leuprorelin; implant, parenteral
126.7
22.8
24
*
GD1AD
NOMESCO Finland
Thorax CT examination
5.4
22.4
47
96
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
22.1
21
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
22.1
21
*
WF002
NOMESCO Finland
Radical radiotherapy
84.6
21.9
24
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
231.2
21.8
22
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.7
21.5
31
43
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
63.3
21.1
24
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
21.0
20
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
21.0
20
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
21.0
20
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
19.9
19
*
KAD52
NOMESCO Finland
Retrograde ureteronephroscopic destruction of tumour of pelvis of kidney
+∞
19.9
19
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
19.9
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
42.2
19.7
24
6
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.0
19.5
106
423
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.9
19.3
27
36
J01EA01
ATC
trimethoprim; systemic
2.8
19.1
126
557
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
18.9
18
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
18.9
18
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.9
18
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.7
18.5
66
203
KCW96
NOMESCO Finland
Other operations on bladder
46.2
18.4
22
5
KBV10
NOMESCO Finland
Removal of stent from ureter
34.6
18.1
23
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
18.0
241
1477
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
17.8
17
*
7126
FHL
Nephroureterectomy
+∞
17.8
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.8
17
*
XKD00
NOMESCO Finland
Uroflowmetry
2.7
17.7
118
522
KA3GB
NOMESCO Finland
Retrograde pyelography
187.3
17.6
18
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
5.4
17.5
36
72
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
+∞
16.8
16
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
16.8
16
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
176.5
16.6
17
*
N02AX02
ATC
tramadol; systemic, rectal
2.3
16.6
220
1329
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.1
16.4
29
50
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
16.3
87
341
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.7
15
*
8000/3-C65.9
ICD-O-3
Neoplasm, malignant of renal pelvis
+∞
15.7
15
*
WX725
NOMESCO Finland
Noninvasive ventilation
4.6
15.6
39
92
KC1GD
NOMESCO Finland
CT cystography of bladder
165.7
15.6
16
*
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
24.4
15.2
21
9
J01MA12
ATC
levofloxacin; systemic
2.6
15.2
113
524
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
15.0
120
576
1530
FHL
Urethrocystoscopy
5.8
15.0
28
51
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
17.3
14.9
23
14
KBB00
NOMESCO Finland
Biopsy of ureter
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
1891C
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,MUU/TARK MÄÄR SYÖPÄ]
+∞
14.7
14
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
14.7
14
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
14.5
42
111
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
14.4
57
187
ZX120
NOMESCO Finland
Intravenous
3.6
14.0
48
143
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.0
13.9
26
25
KA3EB
NOMESCO Finland
Antegrade pyelography
77.6
13.7
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
13.6
13
*
197
Kela drug reimbursment
Sunitinib
+∞
13.6
13
*
U76
ICPC
Malignant neoplasm of bladder
+∞
13.6
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
41.5
13.2
16
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
12.8
163
944
L02BB03
ATC
bicalutamide; oral
+∞
12.6
12
*
U75
ICPC
Malignant neoplasm of kidney
+∞
12.6
12
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
12.6
12
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
12.6
12
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
12.6
12
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.8
12.5
29
64
L02BG04
ATC
letrozole; oral
133.7
12.5
13
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
12.3
43
130
N30.0
ICD-10 Finland
Acute cystitis
2.8
11.8
66
263
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
66.8
11.7
13
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
11.6
91
428
8130/3-C65.9
ICD-O-3
Papillary urothelial carcinoma of renal pelvis
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
11.5
11
*
B03XA02
ATC
darbepoetin alfa; parenteral
9.3
11.4
23
26
ZXC20
NOMESCO Finland
Use of chemical agents
11.0
11.4
21
20
Z3231
NOMESCO Finland
Registered nurse
2.2
11.4
126
686
ZX090
NOMESCO Finland
Other technic of radiotherapy
36.1
11.3
14
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
10.8
58
226
L03AA13
ATC
pegfilgrastim; parenteral
61.5
10.7
12
*
KH1DD
NOMESCO Finland
CT urography of urinary organs
61.5
10.7
12
*
J01DB01
ATC
cefalexin; oral
2.2
10.6
332
2606
Y77
ICPC
Malignant neoplasm prostate
112.6
10.5
11
*
A79
ICPC
Malignancy NOS
112.6
10.5
11
*
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
10.5
10
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
10.5
10
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
10.5
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.5
10
*
KBD00
NOMESCO Finland
Partial excision of ureter
+∞
10.5
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.5
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.5
10
*
KDE20
NOMESCO Finland
Removal of foreign body from urethra
33.4
10.4
13
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.1
10.3
29
75
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
9.9
67
293
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.3
9.8
26
64
ZXE00
NOMESCO Finland
One hour or less
2.0
9.8
165
1037
7321
FHL
TU biopsy, coagulation or laser
56.3
9.7
11
*
WX320
NOMESCO Finland
Spinalanesthesy
2.1
9.6
117
656
ZXA05
NOMESCO Finland
Left side
2.0
9.5
126
728
N02BE01
ATC
paracetamol; systemic, rectal
2.4
9.5
370
3081
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
102.2
9.5
10
*
7125
FHL
Nephrectomy (extrrafascial)
102.2
9.5
10
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
KBC00
NOMESCO Finland
Ureterectomy
+∞
9.4
9
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
9.4
9
*
L01XE04
ATC
[U] sunitinib
+∞
9.4
9
*
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
9.4
9
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
9.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
9.4
9
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
9.4
9
*
KCD30
NOMESCO Finland
Destruction of tumour of bladder
+∞
9.4
9
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
9.8
9.4
18
19
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.4
9.0
23
55
KBV00
NOMESCO Finland
Insertion of stent into ureter
19.1
9.0
13
7
R50.9
ICD-10 Finland
Fever, unspecified
2.4
9.0
70
327
ZXC15
NOMESCO Finland
Use of photodynamic technique
12.9
8.9
15
12
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
8.9
8.9
18
21
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
8.8
49
194
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.0
8.8
25
65
A02BC02
ATC
pantoprazole; systemic
1.9
8.7
279
2128
KCB00
NOMESCO Finland
Biopsy of bladder
51.0
8.7
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
8.5
29
86
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
91.8
8.4
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
91.8
8.4
9
*
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
91.8
8.4
9
*
7323
FHL
Electrosection of TU bladder wall change
91.8
8.4
9
*
R4110
NOMESCO Finland
Physiotherapy
2.0
8.4
117
684
322
Kela drug reimbursment
Sunitinib
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
8.4
8
*
C03CA01
ATC
furosemide; systemic
1.8
8.2
194
1340
WX892
NOMESCO Finland
Monitored bed care
2.7
8.2
46
183
A06AH03
ATC
naloxegol; oral
17.6
8.1
12
7
JFB30
NOMESCO Finland
Right hemicolectomy
34.0
8.1
10
*
J01CA08
ATC
pivmecillinam; oral
1.9
7.9
115
680
UJF32
NOMESCO Finland
Coloscopy
1.9
7.6
113
672
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.2
7.6
20
49
R33
ICD-10 Finland
Retention of urine
2.3
7.6
65
315
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
7.6
80
422
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
81.4
7.4
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
7.3
159
1063
WX704
NOMESCO Finland
Intubation
2.9
7.3
35
128
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
7.3
7
*
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
7.3
7
*
1502
Kela drug reimbursment
Cabozantinib
+∞
7.3
7
*
KBD22
NOMESCO Finland
Retrograde ureteroscopic destruction of tumour of ureter
+∞
7.3
7
*
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
+∞
7.3
7
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
7.3
7
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
3012
Kela drug reimbursment
Cabozantinib
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
WX224
NOMESCO Finland
Blockade of obturius nerve
+∞
7.3
7
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.8
7.3
22
60
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
20.4
7.2
10
5
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.1
7.2
15
19
A06AD11
ATC
lactulose; oral
2.0
7.1
88
492
JEA00
NOMESCO Finland
Appendectomy
3.5
6.9
24
72
H02AB06
ATC
prednisolone; systemic
1.7
6.9
198
1427
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.8
6.8
21
58
TJF80
NOMESCO Finland
Ostomy education
40.7
6.8
8
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
17.0
6.8
10
6
UKD02
NOMESCO Finland
Urethroscopy
17.0
6.8
10
6
XX2RW, ,
NOMESCO Finland
22.9
6.7
9
*
N20.9
ICD-10 Finland
Urinary calculus, unspecified
4.1
6.7
18
45
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.0
6.6
15
22
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
6.5
245
1887
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
70.9
6.4
7
*
KBH20
NOMESCO Finland
Replantation of ureter
70.9
6.4
7
*
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
11.2
6.3
11
10
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
L01EX07
ATC
cabozantinib; oral
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
6.3
6
*
159
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
6.3
6
*
8130/2-C66.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureter
+∞
6.3
6
*
J01MA14
ATC
moxifloxacin; systemic
2.4
6.1
44
198
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.1
183
1324
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
273
1177
4.56
52.79
8.2
3.0
—
—
—
0
0
140
419
4.46
43.11
9.9
5.9
105.11
104.40
mmol/l
0.80
140
419
231
984
3.88
43.05
8.6
3.0
258.70
131.38
e6/l
0.61
197
747
183
671
3.99
42.44
5.8
2.3
3.20
3.82
e6/l
0.80
161
591
210
886
3.65
38.78
8.7
2.9
0.33
0.44
e6/l
0.73
179
658
265
1297
3.68
38.74
3.6
2.3
—
—
—
0
0
134
429
4.07
37.06
8.7
4.6
1.10
1.02
mmol/l
2.01
128
389
235
1113
3.42
35.24
9.4
3.6
111.38
100.70
e6/l
0.15
201
790
77
165
5.46
35.17
3.4
1.3
32.44
2.81
ug/l
0.57
65
128
334
2029
3.80
32.19
10.9
4.5
81.00
835.21
e6/l
—
5
43
101
299
4.10
30.66
9.3
5.7
11.53
11.38
mmol/l
0.06
91
280
118
401
3.67
29.24
9.2
6.3
5.17
5.09
kpa
0.43
110
384
118
401
3.67
29.24
9.2
6.3
13.30
11.16
kpa
4.51
109
385
252
1346
3.08
29.04
7.8
3.6
32.67
35.01
g/l
7.12
233
1227
270
1505
3.10
28.71
10.0
3.7
9.82
12.77
umol/l
5.04
265
1400
128
464
3.49
28.66
5.2
2.5
0.82
0.83
mmol/l
0.19
123
427
158
670
3.14
27.10
2.9
2.1
—
—
—
0
0
114
406
3.45
26.00
9.4
6.3
-0.99
1.44
mmol/l
7.31
89
310
65
155
4.76
25.92
12.7
8.9
23.02
24.67
mmol/l
3.51
60
148
96
317
3.60
24.51
4.8
2.6
236.15
240.27
u/l
0.20
91
296
267
1563
2.84
24.46
11.6
5.5
1.20
1.21
mmol/l
1.61
227
1333
133
545
3.08
23.79
7.9
2.7
1.59
1.01
e6/l
0.68
102
309
249
1433
2.73
23.14
10.9
5.1
1.20
1.21
mmol/l
1.05
235
1271
274
1679
2.71
22.06
20.5
19.9
1.33
1.42
inr
0.72
75
472
297
1918
2.74
21.11
7.8
4.4
6.85
6.92
mmol/l
0.29
285
1795
123
522
2.89
20.29
8.4
2.9
1.02
2.12
e6/l
1.75
93
288
34
56
6.50
20.15
4.1
1.9
83.22
15.31
u/ml
0.47
27
42
259
1593
2.55
19.90
14.1
5.5
4.75
4.48
e9/l
0.67
227
1375
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
112
4.58
18.61
3.8
2.5
0.38
0.40
u/ml
0.07
27
65
182
1001
2.41
17.19
6.7
2.0
2.34
2.35
mmol/l
0.08
160
808
70
238
3.31
16.74
1.6
1.8
0.21
0.19
g/l
1.12
65
208
322
2317
2.51
15.84
12.9
5.1
91.94
77.33
u/l
4.04
313
2101
66
251
2.92
12.92
5.8
3.6
128.63
93.75
ng/l
1.50
55
213
228
1498
2.10
12.86
6.2
3.8
0.00
0.00
estimate
-0.00
55
238
224
1476
2.07
12.38
7.4
5.1
0.00
0.00
estimate
-0.00
55
238
221
1480
2.01
11.36
6.1
3.8
0.00
0.00
estimate
0.50
59
265
79
355
2.50
11.09
6.8
3.2
5.89
5.79
kpa
0.40
72
343
103
529
2.24
10.66
3.6
2.3
10.35
12.81
umol/l
3.28
97
486
77
351
2.45
10.46
6.9
3.2
1.74
2.15
mmol/l
0.37
57
295
90
452
2.25
9.76
4.1
2.3
20.16
23.07
%
1.13
77
387
111
613
2.09
9.45
5.1
2.1
2.50
2.44
mmol/l
6.14
95
503
93
481
2.19
9.36
3.8
2.3
2.06
2.22
g/l
2.00
86
442
12
6
20.51
8.51
2.1
2.3
7.63
5.63
nmol/l
—
12
6
42
161
2.78
8.05
2.2
1.7
1.79
1.59
g/l
0.59
34
138
193
1344
1.79
7.89
6.8
5.1
24.08
25.67
%
0.81
182
1243
138
872
1.85
7.75
2.3
2.2
3.04
3.12
mg/l
0.14
123
718
190
1334
1.75
7.43
6.4
5.0
60.42
58.81
%
0.78
179
1239
116
705
1.88
7.30
5.2
4.1
99.93
368.87
ng/l
2.19
104
606
135
866
1.81
7.13
3.4
2.6
7849.50
10834.77
umol/l
0.22
117
724
12
11
11.18
6.83
1.8
1.1
—
—
—
0
0
50
231
2.32
6.52
3.3
2.0
49.79
57.96
ml/min/173m2
1.14
33
89
96
578
1.85
6.13
2.1
1.8
—
—
—
0
0
351
3031
1.83
5.73
30.1
14.4
38.87
27.06
mg/l
6.71
330
2375
46
218
2.24
5.66
1.5
1.6
—
—
—
0
0
161
1148
1.64
5.55
7.1
4.0
—
—
—
0
0
29
112
2.70
5.51
4.2
3.4
—
—
—
0
0
32
133
2.52
5.27
1.7
1.6
2.69
2.99
ug/l
0.06
26
112
121
815
1.67
5.15
7.7
4.0
0.00
0.00
estimate
-0.00
44
229
46
228
2.14
5.08
6.9
3.8
1.91
2.06
mmol/l
0.07
34
166
52
273
2.03
4.94
3.1
1.5
66.73
66.94
g/l
0.06
44
240
71
416
1.84
4.89
2.1
1.8
—
—
—
0
0
55
301
1.95
4.66
4.3
2.7
5.10
4.53
kpa
0.48
49
286
59
333
1.89
4.56
5.5
3.2
—
—
—
0
0
17
54
3.24
4.53
1.1
1.2
—
—
—
0
0
70
418
1.80
4.53
2.1
1.8
—
—
—
0
0
42
214
2.07
4.33
1.7
1.5
—
—
—
0
0
220
1764
1.50
4.19
4.6
4.0
2.56
2.06
ug/l
0.76
175
1550
157
1187
1.51
3.91
4.0
2.6
254.07
158.07
ug/l
1.28
143
1057
267
2250
1.49
3.84
4.1
4.0
19.83
13.17
mm/h
5.36
238
2020
14
44
3.25
3.81
1.1
1.2
—
—
—
0
0
12
29
4.23
3.73
2.6
1.4
—
—
—
0
0
18
70
2.64
3.42
1.1
1.3
—
—
—
0
0
21
89
2.43
3.37
1.1
1.6
—
—
—
0
0
57
351
1.72
3.32
3.9
3.5
369.16
249.22
ng/l
0.75
50
327
13
43
3.09
3.27
1.1
1.2
—
—
—
0
0
17
66
2.64
3.25
1.1
1.3
—
—
—
0
0
13
39
3.40
3.25
1.2
1.2
—
—
—
0
0
13
40
3.32
3.16
1.2
2.0
282.92
305.17
mu/l
0.09
13
35
13
44
3.01
3.16
1.1
1.3
—
—
—
0
0
13
44
3.01
3.16
1.1
1.3
—
—
—
0
0
8
16
5.07
3.06
1.0
1.2
—
—
—
0
0
8
16
5.07
3.06
1.0
1.2
—
—
—
0
0
87
614
1.52
2.92
1.7
1.7
2.09
1.33
mg/l
1.30
75
474
24
116
2.13
2.88
1.1
1.2
94.83
126.33
iu/ml
—
6
44
356
3258
1.52
2.81
39.6
17.7
138.84
139.76
mmol/l
7.44
349
3136
140
1094
1.41
2.77
1.9
2.2
113.98
326.55
u/l
2.32
129
1012
356
3265
1.50
2.71
40.3
17.8
4.12
4.02
mmol/l
7.31
349
3143
315
2825
1.42
2.69
32.2
13.3
57.33
73.19
ml/min/173m2
27.25
290
2281
10
30
3.39
2.62
6.2
1.5
—
—
—
0
0
286
2532
1.38
2.57
40.3
16.3
15.52
15.26
%
0.33
280
2465
151
1212
1.38
2.52
3.2
3.2
3910.79
1807.73
ng/l
2.15
140
1044
350
3213
1.46
2.51
16.3
9.0
24.08
26.22
u/l
1.52
336
3043
143
1138
1.38
2.51
3.0
3.1
6.79
7.70
mmol/l
1.99
115
931
36
213
1.75
2.45
2.4
1.6
—
—
—
0
0
123
964
1.39
2.35
3.1
2.7
0.96
0.78
ug/l
0.59
76
651
6
13
4.66
2.28
1.0
1.0
—
—
—
0
0
6
13
4.66
2.28
1.0
1.2
—
—
—
0
0
94
709
1.42
2.24
7.3
4.1
1.02
1.02
kg/l
0.17
16
107
146
1188
1.35
2.18
3.5
3.8
24.62
8.61
mg/mmol
2.27
98
764
15
68
2.25
2.13
1.7
1.4
—
—
—
0
0
5
10
5.04
2.07
1.0
1.1
—
—
—
0
0
24
133
1.85
2.04
2.2
1.5
—
—
—
0
0
10
39
2.60
1.95
2.0
1.4
—
—
—
0
0
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
8
27
3.00
1.94
1.1
1.4
—
—
—
0
0
357
3333
1.40
1.94
46.0
20.8
246.02
233.60
e9/l
2.44
349
3203
357
3333
1.40
1.94
46.8
20.8
36.99
40.00
%
11.43
330
3019
22
121
1.86
1.92
2.1
1.4
—
—
—
0
0
6
17
3.56
1.84
1.2
1.2
—
—
—
0
0
5
12
4.20
1.83
1.0
1.2
—
—
—
0
0
5
12
4.20
1.83
1.0
1.2
—
—
—
0
0
356
3334
1.38
1.80
46.1
20.8
4.20
4.48
e12/l
17.27
345
3182
11
47
2.38
1.79
1.0
1.4
—
—
—
0
0
173
1477
1.28
1.76
2.2
2.1
87.82
92.54
pmol/l
0.83
101
760
243
2165
1.28
1.76
4.3
3.4
15.06
15.12
pmol/l
0.15
214
1906
12
55
2.22
1.69
3.3
1.4
—
—
—
0
0
15
76
2.01
1.66
1.2
1.4
—
—
—
0
0
166
1422
1.27
1.62
4.4
3.8
23.22
24.59
%
0.55
86
690
5
14
3.60
1.62
2.4
2.9
—
—
—
0
0
15
78
1.96
1.56
3.7
1.9
15.90
15.88
%
—
8
40
167
1438
1.26
1.55
4.6
4.2
53.33
69.48
ng/l
0.26
138
1111
8
33
2.45
1.54
1.4
1.2
—
—
—
0
0
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
8
33
2.45
1.54
1.0
1.5
—
—
—
0
0
140
1183
1.27
1.51
2.1
2.2
76.18
77.31
nmol/l
0.17
122
999
7
28
2.52
1.45
1.0
1.3
—
—
—
0
0
5
16
3.15
1.44
1.4
1.1
—
—
—
0
0
203
1802
1.24
1.41
3.5
3.0
71.34
53.29
u/l
1.04
190
1637
12
61
1.99
1.34
1.3
1.6
—
—
—
0
0
9
44
2.07
1.27
3.0
2.6
64.11
59.84
%
—
9
44
94
772
1.28
1.27
1.8
1.8
1043.51
1156.00
nmol/l
0.48
74
572
6
25
2.42
1.24
1.7
1.1
—
—
—
0
0
21
134
1.60
1.16
3.0
1.2
—
—
—
0
0
7
30
2.35
1.13
1.0
1.3
—
—
—
0
0
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
17
105
1.64
1.07
1.1
1.3
—
—
—
0
0
9
46
1.98
1.04
1.3
1.1
—
—
—
0
0
18
115
1.59
1.01
1.6
1.6
—
216.67
—
0
6
0
31
0.00
0.96
0.0
2.3
—
—
—
0
0
157
1408
1.18
0.90
2.4
2.3
—
—
—
0
0
8
42
1.92
0.89
1.0
1.3
—
—
—
0
0
8
45
1.79
0.84
3.8
3.9
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
1.02
—
0
13
10
162
0.61
0.78
2.0
1.9
—
—
—
0
0
104
911
1.19
0.78
1.6
1.6
16.60
20.11
nmol/l
2.16
92
757
0
27
0.00
0.77
0.0
1.2
—
171.65
—
0
27
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
42
518
0.79
0.73
1.2
1.2
0.62
1.74
u/ml
—
10
138
10
60
1.68
0.72
1.1
1.2
—
—
—
0
0
22
160
1.40
0.72
2.9
2.3
404.22
674.80
ug/l
0.34
22
148
5
26
1.93
0.71
1.0
1.5
—
—
—
0
0
5
26
1.93
0.71
1.2
2.7
—
—
—
0
0
34
427
0.78
0.68
1.2
1.3
13.90
41.85
iu/ml
—
10
126
7
42
1.68
0.68
1.1
1.4
0.74
0.69
nmol/l
—
7
37
7
42
1.68
0.68
1.1
1.4
—
0.14
nmol/l
—
0
5
92
808
1.18
0.67
1.6
1.8
399.77
421.44
pmol/l
0.40
70
648
6
103
0.58
0.63
1.5
1.8
44.00
42.58
nmol/l
—
6
97
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
32
392
0.80
0.55
1.2
1.3
17.51
11.58
u/ml
0.15
13
129
13
91
1.44
0.53
1.4
1.3
—
—
—
0
0
45
384
1.19
0.48
2.8
2.8
3.37
7.71
ug/l
4.14
39
330
72
806
0.87
0.47
1.6
1.7
1.42
1.30
mmol/l
0.68
59
644
285
2745
1.11
0.46
5.5
4.3
2.03
2.00
mu/l
0.12
257
2429
32
266
1.22
0.45
1.0
1.3
—
—
—
0
0
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
5
33
1.52
0.41
1.2
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
1.07
—
0
7
0
16
0.00
0.41
0.0
1.3
—
200.50
—
0
16
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
18
142
1.28
0.39
1.3
1.3
—
—
—
0
0
8
112
0.71
0.37
1.0
1.3
—
—
—
0
0
5
37
1.36
0.37
1.0
1.0
—
—
—
0
0
5
77
0.65
0.36
1.8
2.0
177.40
228.46
pmol/l
—
5
71
278
2862
0.92
0.34
4.2
4.3
1.40
1.28
mmol/l
1.05
244
2546
6
86
0.69
0.33
1.0
1.2
—
—
—
0
0
6
86
0.69
0.33
1.0
1.2
—
—
—
0
0
12
97
1.24
0.23
1.2
1.7
—
—
—
0
0
290
2960
0.94
0.23
4.5
4.8
1.30
1.39
mmol/l
3.13
259
2655
293
2989
0.94
0.22
4.6
4.9
4.15
4.35
mmol/l
2.71
260
2708
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
12
144
0.83
0.20
1.4
1.2
199.63
210.42
u/ml
0.04
12
129
5
67
0.74
0.17
1.0
1.6
—
—
—
0
0
9
79
1.14
0.15
1.4
1.4
—
—
—
0
0
9
79
1.14
0.15
1.4
1.4
—
—
—
0
0
10
86
1.17
0.11
1.2
1.6
—
—
—
0
0
307
3038
1.04
0.10
5.4
5.0
6.16
6.18
mmol/l
0.11
269
2692
41
432
0.94
0.10
4.2
4.9
32.62
32.92
%
0.05
26
285
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
5
62
0.80
0.08
1.0
1.3
3.52
4.31
mmol/l
—
5
57
7
81
0.86
0.07
1.6
1.6
55861.14
16032.23
e6/l
—
7
62
9
102
0.88
0.06
1.0
1.0
—
—
—
0
0
306
3072
0.99
0.02
5.0
5.5
2.33
2.53
mmol/l
3.99
264
2761
45
441
1.02
0.02
13.5
8.3
—
—
—
0
0
294
2941
1.00
0.00
7.3
6.6
41.37
41.47
mmol/mol
0.06
262
2675
8
84
0.95
0.00
1.4
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
1.24
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
2092.67
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
10.06
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.2
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_RENAL_PELVIS_WIDE – Malignant neoplasm of renal pelvis, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).